US4140755A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Sustained release tablet formulations
Assignee: Hoffmann La Roche Inc
•
Filing: 1978-01-25
•
Granted: 1979-02-20
•
Expires: 1998-01-25
Abstract
Abstract A novel sustained release formulation for the preparation of tablets for oral administration is disclosed. The formulation is hydrodynamically balanced to be buoyant in gastric juice thereby remaining in the stomach for an extended period of time.
Inventors
- 👤 Prabhakar R. Sheth
- 👤 Jacques L. Tossounian
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 09:11
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0065
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
183 words
A two-layer tablet comprising: a first layer containing one or more antacid substances and therapeutically inert pharmaceutically acceptable adjunct materials free of sustained release ingredients; and a second layer containing as the active ingredient, one or more antacid compounds, said tablet being hydrodynamically balanced so that, upon contact with gastric fluid, said second layer acquires and maintains a bulk density of less than one thereby being buoyant in said fluid and remaining buoyant in the gastric fluid of the stomach until substantially all of the antacid compounds contained therein have been released therefrom, said second layer comprising a homogeneous mixture of said antacid compounds, from about 0% to about 80% by weight of therapeutically inert, pharmaceutically acceptable adjunct materials, and from about 20% by weight to about 75% by weight of one or a mixture of hydrocolloids selected from the group consisting of methylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose and sodium carboxymethylcellulose to provide, upon contact with gastric fluid, a water impermeable barrier on the surface of said second layer, said tablet being compressed to a hardness of from about 12 to about 14 S.C.U.
Claim 2
Dependent Claim
183 words
A two-layer tablet comprising: a first layer containing one or more antacid substances and therapeutically inert pharmaceutically acceptable adjunct materials free of sustained release ingredients; and a second layer containing as the active ingredient, one or more antacid compounds, said tablet being hydrodynamically balanced so that, upon contact with gastric fluid, said second layer acquires and maintains a bulk density of less than one thereby being buoyant in said fluid and remaining buoyant in the gastric fluid of the stomach until substantially all of the antacid compounds contained therein have been released therefrom, said second layer comprising a homogeneous mixture of said antacid compounds, from about 0% to about 80% by weight of therapeutically inert, pharmaceutically acceptable adjunct materials, and from about 20% by weight to about 75% by weight of one or a mixture of hydrocolloids selected from the group consisting of methylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose and sodium carboxymethylcellulose to provide, upon contact with gastric fluid, a water impermeable barrier on the surface of said second layer, said tablet being compressed to a hardness of from about 12 to about 14 S.C.U.
References Cited (Backward Citations)
US3065143A
Cited
US3418999A
Cited
US3427378A
Cited
US3444290A
Cited
US3555151A
Cited
US3574820A
Cited
US3976764A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-02-19 | 1982-08-21 | 1983-02-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-02-19 | 1986-08-21 | 1987-02-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-02-19 | 1990-08-21 | 1991-02-20 | $7700.00 | Window Closed / Lapsed |